Non-specific Response to H1N1 Vaccine

The University Clinic of Pulmonary and Allergic Diseases Golnik14 enrolled

Overview

This is a prospective observational study with recruitment of healthy volunteers from consecutive recipients of H1N1 influenza vaccine at the University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia. The purpose of this study is to evaluate certain safety aspects of adjuvanted influenza H1N1 vaccines.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Influenza H1N1

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Recipients of H1N1 influenza vaccine. * Healthy individuals with no signs of influenza or other infectious disease. Exclusion Criteria: * Signs of influenza or other infectious disease in 1 month before study participation.

Locations (1)

University Clinic of Respiratory and Allergic Diseases

Golnik, Slovenia

Outcomes

Primary Outcomes

T Cell Immune response monitoring after Influenza A (H1N1) AS03-Adjuvanted Vaccination

Time frame: At 3 weeks after vaccination

T Cell Immune response monitoring after Influenza A (H1N1) AS03-Adjuvanted Vaccination

Time frame: At 11 weeks after vaccination.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.